Ultrawash Mouth Rinse

Introduction

Ultrawash Mouth Rinse is a prescription medication that contains the active ingredient Benzydamine.

Uses

Ultrawash Mouth Rinse is commonly prescribed for the treatment of oral conditions such as mouth ulcers, sore throat, and inflammation of the gums. It helps to relieve pain, reduce swelling, and promote healing in the affected areas.

Dosage and Administration

The recommended dosage of Ultrawash Mouth Rinse is usually 15 milliliters (one tablespoon) of mouthwash, to be used three to four times a day, or as directed by your healthcare provider. You should swish the mouthwash around your mouth for at least 30 seconds before spitting it out. Follow the instructions provided by your healthcare provider for the specific duration of treatment.

Mechanism of Action

Benzydamine, the active ingredient in Ultrawash Mouth Rinse, belongs to a class of medications called non-steroidal anti-inflammatory drugs (NSAIDs). It works by reducing the production of inflammatory substances in the body, thereby helping to alleviate pain, swelling, and inflammation in the mouth and throat.

Side Effects

Common side effects include a temporary numbing or tingling sensation in the mouth, altered taste sensation, and a feeling of dryness in the mouth. These side effects are usually mild and do not require medical attention.

However, if you experience any serious side effects such as rash, itching, difficulty breathing, or swelling of the face, lips, tongue, or throat, seek immediate medical attention.

Drug Interactions

Ultrawash Mouth Rinse may interact with certain medications. Inform your healthcare provider about all the medications you are currently taking, including prescription, over-the-counter, and herbal products. Some medications that may interact with Ultrawash Mouth Rinse include blood thinners, anticoagulants, and certain antidepressants. Your healthcare provider will be able to determine if any potential drug interactions exist and advise you accordingly.

Precautions

Before using Ultrawash Mouth Rinse, inform your healthcare provider about any allergies you may have, especially if you are allergic to NSAIDs or any other medications. You should also inform your healthcare provider about any medical conditions you have, such as asthma or stomach ulcers.

Avoid swallowing the mouthwash and to seek medical attention if accidental ingestion occurs. Ultrawash Mouth Rinse is not recommended for use in children under the age of 12 years without medical supervision.

Storage

Ultrawash Mouth Rinse should be stored at room temperature, away from direct sunlight and heat. Keep it out of the reach of children and pets. Do not use the mouthwash if the expiration date has passed.

Patient Tips

• Use Ultrawash Mouth Rinse as directed by your healthcare provider.
• Do not swallow the mouthwash; it is for external use only.
• Avoid eating or drinking for at least 30 minutes after using the mouthwash to allow it to take effect.
• If you accidentally swallow the mouthwash, contact your healthcare provider or seek medical attention immediately.
• If your symptoms do not improve or worsen after a few days of using Ultrawash Mouth Rinse, consult your healthcare provider.

Please note that this description, as well as the other content on our website is for educational purposes only. We do not provide medical advice. For specific medical advices, diagnoses and treatment options you should consult with your doctor.

References

• Benzydamine – a non-steroidal anti-inflammatory (NSAID) used for teething, sore throats and mouth ulcers. (NHS UK) [Accessed 0 Jun. 2024] (online) Available at:
• Benzydamine 0.15% w/v Mouthwash (Health Professionals SmPC) Available at:
• Benzydamine (International database) (Drugs.com) [Accessed 29 Jun. 2024] (online) Available at:
• FMO3 gene (MedlinePlus) [Accessed 4 Jun. 2024] (online) Available at:
• Ősz BE, Jîtcă G, Sălcudean A, Rusz CM, Vari CE. Benzydamine-An Affordable Over-the-Counter Drug with Psychoactive Properties-From Chemical Structure to Possible Pharmacological Properties. Pharmaceuticals (Basel). 2023 Apr 10;16(4):566. doi: 10.3390/ph16040566. [Accessed 4 Jun. 2024] Available at: